Yoshitaka Nishikawa, Yasuaki Ozawa, Masaharu Tsubokura, Akihiko Ozaki, Toyoaki Sawano, Tomohiro Morita, Naoto Yoshida and Fumio Fujii.

Long-term vulnerability of access to hemodialysis facilities in repopulated areas after the Fukushima Nuclear Disaster: a case report

Oxf Med Case Reports. 2018;7, 228–230

Yoshitaka Nishikawa, Hideki Yokoi, Takaki Sakurai, Takahiro Horimatsu, and Shin’ichi Miyamoto.

Lanthanum deposition in the gastric mucosa in a patient undergoing hemodialysis

QJM. 2018 May 1;111(5):347-348.

Yosuke Fujii, Yoshitaka Nishikawa, Motoo Nomura, Shin’ich Miyamto, Yu Uneno, Takahiro Horimatsu, and Manabu Muto.

Readministration of Nivolumab after Persistent Immune-Related Colitis in a Patient with Recurrent Melanoma

Intern Med. 2018 Apr 15;57(8):1173-1176.

Yoshihide Mitsuda, Ken Morita, Gengo Kashiwazaki, Junichi Taniguchi, Toshikazu Bando, Masahiro Hirata, Moeka Obara, Tatsuki R Kataoka, Manabu Muto,Yasufumi Kaneda, Tatsutoshi Nakahata, Pu Paul Liu, Souichi Adachi, Hiroshi Sugiyama and Yasuhiko Kamikubo.

RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells.

Sci Rep. 2018 Apr 23;8(1):6423.

Tamaoki Masashi, Komatsuzaki Rie, Komatsu Masayuki, Minashi Keiko, Aoyagi Kazuhiko, Nishimura Takao, Chiwaki Fumiko, Hiroki Tomoko, Daiko Hiroyuki, Morishita Kazuhiro, Sakai Yoshiharu, Seno Hiroshi, Chiba Tsutomu, Muto Manabu, Yoshida Teruhiko, Sasaki Hiroki.

Multiple roles of SIM2 in esophageal squamous cell carcinoma and its clinical implications

Cancer Sci. 2018 Apr;109(4):1121-1134.

Hiroki Nagai, Manabu Muto.

Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update

Int J Clin Oncol. 2018 Jun;23(3):410-420.

Tomohiro Kondo, Masashi Kanai, Tadayuki Kou, Tomohiro Sakuma, Hiroaki Mochizuki, Mayumi Kamada, Masahiko Nakatsui, Norimitsu Uza, Yuzo Kodama,Toshihiko Masui, Kyoichi Takaori, Shigemi Matsumoto, Hidehiko Miyake, Yasushi Okuno and Manabu Muto.

Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer.

Oncotarget. 2018 Apr 13;9(28):19817-19825.

Motoo Nomura, Atsushi Otsuka, Michio Yoshimura, Yumi Nonomura, Yo Kaku, Shigemi Matsumoto, Manabu Muto.

Efficacy and safety of concurrent immunoradiotherapy in patients with metastatic melanoma after progression on nivolumab

Cancer Chemother Pharmacol. 2018 May;81(5):823-827.

Yamada A, Yu P, Lin W, Okugawa Y, Boland CR, Goel A.

A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer.

Sci Rep. 2018 Jan 12;8(1):575.

Kanesaka T, Uedo N, Yao K, Ezoe Y, Doyama H, Oda I, Kaneko K, Kawahara Y, Yokoi C, Sugiura Y, Ishikawa H, Takeuchi Y, Arao M, Iwatsubo T, Iwagami H, Matsuno K, Muto M, Saito Y, Tomita Y.

Multiple convex demarcation line for prediction of benign depressed gastric lesions in magnifying narrow-band imaging.

Endosc Int Open. 2018 Feb;6(2):E145-E155.